Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Titel:
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Auteur:
Burns, Daniel K Alexander, Robert C Welsh-Bohmer, Kathleen A Culp, Meredith Chiang, Carl O’Neil, Janet Evans, Rebecca M Harrigan, Patrick Plassman, Brenda L Burke, James R Wu, Jingtao Lutz, Michael W Haneline, Stephen Schwarz, Adam J Schneider, Lon S Yaffe, Kristine Saunders, Ann M Ratti, Emiliangelo